Advertisement

Topics

Magnolia Neurosciences launches with $31mm Series A round

15:40 EDT 14 Aug 2018 | Elsevier Business Intelligence

With a $31mm Series A round, Accelerator Life Science Partners launched Magnolia Neurosciences Corp. (neuroprotective therape...

Original Article: Magnolia Neurosciences launches with $31mm Series A round

NEXT ARTICLE

More From BioPortfolio on "Magnolia Neurosciences launches with $31mm Series A round"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...